TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19064019

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (1:1 dose ratio)
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (1:2 dose ratio)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Rosuvastatin (1:4 dose ratio)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Atorvastatin (1:1 dose ratio)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Atorvastatin (1:2 dose ratio)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Atorvastatin (1:4 dose ratio)
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: Both treatments (Rosuvastatin and Atorvastatin)
Number of subjects: 20000
Study: 16188182

Group type: COMPARATOR
Intervention: 20 U of botulinum toxin type A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 40 U of botulinum toxin type A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 60 U of botulinum toxin type A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 80 U of botulinum toxin type A
Number of subjects: 80
Study: 12540398

Group type: EXPERIMENTAL
Intervention: High-fiber rye bread
Number of subjects: 20

Group type: COMPARATOR
Intervention: White-wheat bread
Number of subjects: 20
Study: 11072457

Group type: EXPERIMENTAL
Intervention: 2-mg sublingual nicotine tablets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 20
Study: 9040899

Group type: EXPERIMENTAL
Intervention: Resistance training (90 min/day, 3-4 times/week for six weeks)
Number of subjects: 8
Study: 1494208

Group type: EXPERIMENTAL
Intervention: Intermittent tube feeding
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous tube feeding
Number of subjects: 60
Study: 4028617

Group type: EXPERIMENTAL
Intervention: Amoxycillin 375 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amoxycillin 750 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amoxycillin 1500 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bacampicillin 400 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bacampicillin 800 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bacampicillin 1600 mg
Number of subjects: 12
Study: 30903372

Group type: EXPERIMENTAL
Intervention: Anti-HEV IgG testing using ELISA-1, ELISA-2, ELISA-3, and strip-immunoassay
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Travel abroad or eating of red meat
Number of subjects: 1800
Study: 29732978

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) 4 g for 1 hour followed by 1 g over 6 hours infusion
Number of subjects: 248

Group type: COMPARATOR
Intervention: Prostaglandin analogue
Number of subjects: 248
Study: 27442653

Group type: EXPERIMENTAL
Intervention: Hydrogel-coated ventricular peritoneum shunts (VPS)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard silastic VPS catheters
Number of subjects: 78
Study: 24929455

Group type: EXPERIMENTAL
Intervention: Acupuncture (5 sessions of 30 minutes on specific points)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Corticosteroid injection (1 injection of methylprednisolone acetate)
Number of subjects: 30
Study: 22681971

Group type: EXPERIMENTAL
Intervention: 0.2 μg/kg/h intravenous dexmedetomidine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 0.4 μg/kg/h intravenous dexmedetomidine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 0.6 μg/kg/h intravenous dexmedetomidine
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 20921442

Group type: EXPERIMENTAL
Intervention: Enhanced external counterpulsation (EECP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham EECP
Number of subjects: 42
Study: 18800598

Group type: EXPERIMENTAL
Intervention: Oral poliovirus vaccine (OPV)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 15677598

Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus medication
Number of subjects: 103

Group type: COMPARATOR
Intervention: Medication only
Number of subjects: 103
Study: 11579351

Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg per day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: COMPARATOR
Intervention: Nondepressed reference group
Number of subjects: 38
Study: 9643273

Group type: EXPERIMENTAL
Intervention: mibefradil
Number of subjects: 66

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 66
Study: 7936303

Group type: EXPERIMENTAL
Intervention: BUdR alone
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: BUdR + 5-FU
Number of subjects: 62

Group type: COMPARATOR
Intervention: Both trials (BUdR alone and BUdR + 5-FU)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Grade IV patients
Number of subjects: 62
Study: 3344727

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2038928

Group type: EXPERIMENTAL
Intervention: Adenosine (90 +/- 20 micrograms.kg-1.min-1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside (0.7 +/- 0.1 micrograms.kg-1.min-1)
Number of subjects: 6
Study: 268332

Group type: EXPERIMENTAL
Intervention: Mechanical toothcleaning procedures once a day (Group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mechanical toothcleaning procedures once every second day (Group B)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mechanical toothcleaning procedures once every third day (Group C)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mechanical toothcleaning procedures once every fourth day (Group D)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthrinse once daily (Group A in maxillary areas)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Localized plaque accumulation with no oral hygiene (control)
Number of subjects: 20
Study: 31685078

Group type: EXPERIMENTAL
Intervention: Systematic feedback based on the behavioral component of a feedback protocol
Number of subjects: 98

Group type: COMPARATOR
Intervention: Systematic feedback based on the entire protocol
Number of subjects: 98
Study: 30156134

Group type: EXPERIMENTAL
Intervention: Self-report during a telephone interview
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Four-item questionnaire
Number of subjects: 29

Group type: COMPARATOR
Intervention: Clinical and radiographic examination (gold standard)
Number of subjects: 29
Study: 28275131

Group type: EXPERIMENTAL
Intervention: Catechin beverage (615 mg catechin and 77 mg caffeine)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo beverage (82 mg caffeine)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Catechin beverage (daily ingestion for 5 weeks)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo beverage (daily ingestion for 5 weeks)
Number of subjects: 15
Study: 25541647

Group type: EXPERIMENTAL
Intervention: Genetic variation in PEAR1 (nine single nucleotide polymorphisms)
Number of subjects: 1973
Study: 23642785

Group type: EXPERIMENTAL
Intervention: Monthly ranibizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monthly bevacizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PRN ranibizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PRN bevacizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 0
Study: 21342355

Group type: EXPERIMENTAL
Intervention: 20% olive oil-based intravenous lipid emulsion (ILE)
Number of subjects: 64

Group type: COMPARATOR
Intervention: 20% soybean oil-based intravenous lipid emulsion (ILE)
Number of subjects: 64
Study: 19226569

Group type: EXPERIMENTAL
Intervention: 1,450 nm diode laser treatment
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 14
Study: 17126585

Group type: EXPERIMENTAL
Intervention: High dose corticosteroid treatment (8-12 weeks)
Number of subjects: 37
Study: 15936511

Group type: EXPERIMENTAL
Intervention: Active rTMS (1 Hz at 90% resting motor threshold for 15 minutes, 4 sessions over 4 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 16
Study: 11322354

Group type: EXPERIMENTAL
Intervention: Fibromyalgia Treatment Program
Number of subjects: 100
Study: 9385869

Group type: EXPERIMENTAL
Intervention: Invisible spatial transformations with varying orientation cues, path of motion, and amount of transformation; specific details on dosage and duration not applicable.
Number of subjects: 0
Study: 7899788

Group type: EXPERIMENTAL
Intervention: Albendazole 800 mg x 3 daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albendazole 1200 mg x 3 daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albendazole with a fatty breakfast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ivermectin administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albendazole administered 5-7 days after ivermectin
Number of subjects: 0
Study: 3110848

Group type: EXPERIMENTAL
Intervention: d-amphetamine (0.5 mg/kg PO)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo or no treatment
Number of subjects: 16
Study: 31786150

Group type: EXPERIMENTAL
Intervention: RAP Club (trauma-informed intervention including mindfulness)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Health education active control group
Number of subjects: 800
Study: 29221604

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 619
Study: 29116126

Group type: EXPERIMENTAL
Intervention: Clinical predictors including demographics, anthropometrics, cardiac and blood measures, diet and exercise, physical and mental health, medication
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Genetic polygenic risk scores (PRS) for schizophrenia, bipolar disorder, BMI, waist‐hip‐ratio, insulin resistance and height, gene co‐expression modules from WGCNA
Number of subjects: 284
Study: 26285130

Group type: EXPERIMENTAL
Intervention: Escitalopram and statins together
Number of subjects: 446

Group type: COMPARATOR
Intervention: Neither medication
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Lipophilic statins
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 446
Study: 23331081

Group type: COMPARATOR
Intervention: Buccal infiltration (BI) group: 40 patients received supplemental BI of 0.9 mL of 4% articaine with 1 : 100,000 epinephrine.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Buccal plus lingual infiltration (BLI) group: 40 patients received supplemental BI of 0.9 mL of 4% articaine with 1 : 100,000 epinephrine and LIs with the same anaesthetic solution and dose.
Number of subjects: 80
Study: 21417518

Group type: EXPERIMENTAL
Intervention: Active maintenance of memory traces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive load
Number of subjects: 0
Study: 18559401

Group type: EXPERIMENTAL
Intervention: TAAG intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical activity programs in intervention schools
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 0
Study: 17143239

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (n = 14)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (n = 4)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (both types)
Number of subjects: 18
Study: 14611705

Group type: EXPERIMENTAL
Intervention: Salt restricted mothers (n = 76)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Control mothers (n = 328)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Both groups (Salt restricted and Control)
Number of subjects: 404
Study: 11759870

Group type: COMPARATOR
Intervention: Non-porous teflon barrier membrane plus demineralized freeze dried bone allograft (DFDBA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Porous teflon barrier membrane plus demineralized freeze dried bone allograft (DFDBA)
Number of subjects: 24
Study: 9387969

Group type: EXPERIMENTAL
Intervention: Tetracycline (1.5 g)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Bleomycin (60 mg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Bleomycin
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 62
Study: 7910473

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg day‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg day‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Famotidine (40 mg day‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study: 3352332

Group type: EXPERIMENTAL
Intervention: E5 scale (five-point scale ranging from 'excellent' to 'poor')
Number of subjects: 499

Group type: COMPARATOR
Intervention: S6 scale (six-point response scale ranging from 'very satisfied' to 'very dissatisfied')
Number of subjects: 499
Study: 31257092

Group type: EXPERIMENTAL
Intervention: tDCS (30-min sessions of 2 mAmp direct current over the dorsolateral prefrontal cortex, 5 days per week, for 3 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham-control (sham stimulation with current turned off after 30 seconds)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham-control
Number of subjects: 20
Study: 27527398

Group type: EXPERIMENTAL
Intervention: RME+WRDT
Number of subjects: 1659

Group type: COMPARATOR
Intervention: RME-only
Number of subjects: 1659
Study: 25716362

Group type: EXPERIMENTAL
Intervention: Whole-brain radiotherapy (WBRT) after high-dose methotrexate (HDMTX)-based chemotherapy
Number of subjects: 410

Group type: COMPARATOR
Intervention: High-dose methotrexate (HDMTX)-based chemotherapy alone
Number of subjects: 410
Study: 23590840

Group type: EXPERIMENTAL
Intervention: Healthy bipolar offspring (HBO)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Healthy control (HC)
Number of subjects: 31
Study: 21714640

Group type: EXPERIMENTAL
Intervention: Late initiation of parenteral nutrition (not initiated before day 8)
Number of subjects: 4640

Group type: EXPERIMENTAL
Intervention: Late initiation of parenteral nutrition
Number of subjects: 4640

Group type: COMPARATOR
Intervention: Early initiation of parenteral nutrition (initiated within 48 hours after ICU admission)
Number of subjects: 4640
Study: 19662781

Group type: EXPERIMENTAL
Intervention: Preoperative epidural clonidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preoperative levobupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 0
Study: 16757526

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) supplementation
Number of subjects: 54
Study: 15342289

Group type: EXPERIMENTAL
Intervention: Nesiritide infusions at dosages of 0.005 or 0.01 microg/kg/min for 12 weeks
Number of subjects: 210

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 210
Study: 10926959

Group type: EXPERIMENTAL
Intervention: Integrated Care Pathway (ICP) care coordinated by an experienced nurse
Number of subjects: 152

Group type: COMPARATOR
Intervention: Conventional multidisciplinary care
Number of subjects: 152
Study: 8604440

Group type: EXPERIMENTAL
Intervention: Holter monitor (HM) limb
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Electrophysiologic study (EPS) limb
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: EPS testing with concordant versus discordant efficacy prediction
Number of subjects: 215

Group type: COMPARATOR
Intervention: Noninvasive versus invasive limbs in ESVEM
Number of subjects: 215
Study: 1390333

Group type: EXPERIMENTAL
Intervention: Intravenous bepridil (2 mg/kg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oral bepridil (500 mg/day)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oral bepridil (900 mg/day)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oral bepridil (300 mg/day)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oral bepridil (600 mg/day)
Number of subjects: 38
Study: 3935405

Group type: EXPERIMENTAL
Intervention: Insulin-glibenclamide combination therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Insulin-placebo treatment
Number of subjects: 18
Study: 30964413

Group type: EXPERIMENTAL
Intervention: Anopheles gambiae s.l. in rural areas
Number of subjects: 10367

Group type: EXPERIMENTAL
Intervention: Culex quinquefasciatus in urban areas
Number of subjects: 10367

Group type: COMPARATOR
Intervention: Indoor Residual Spraying (IRS)
Number of subjects: 10367
Study: 29117299

Group type: EXPERIMENTAL
Intervention: High-dose triamcinolone acetonide (40 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Low-dose triamcinolone acetonide (20 mg)
Number of subjects: 32
Study: 27056132

Group type: EXPERIMENTAL
Intervention: Artemisinin-naphthoquine (AN)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Presence of P. vivax asexual forms
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Baseline P. falciparum gametocytaemia
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Baseline P. vivax gametocytaemia
Number of subjects: 230
Study: 24851040

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate 20 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate 80 mg/day
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combination of isosorbide dinitrate and ibuprofen
Number of subjects: 19
Study: 22892744

Group type: EXPERIMENTAL
Intervention: 2% liquid CHX
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 2% gel CHX
Number of subjects: 45

Group type: COMPARATOR
Intervention: Distilled water (control group)
Number of subjects: 45
Study: 20159177

Group type: EXPERIMENTAL
Intervention: Continuous use of 30 mcg ethinylestradiol and 3 mg drospirenone for 168 days
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Continuous use of 30 mcg ethinylestradiol and 3 mg drospirenone
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cyclic use of 30 mcg ethinylestradiol and 3 mg drospirenone for six 28‐day cycles
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cyclic use of 30 mcg ethinylestradiol and 3 mg drospirenone
Number of subjects: 78
Study: 17646619

Group type: EXPERIMENTAL
Intervention: 10-cm² rivastigmine patch (9.5 mg/24 hours)
Number of subjects: 1195

Group type: EXPERIMENTAL
Intervention: 20-cm² rivastigmine patch (17.4 mg/24 hours)
Number of subjects: 1195

Group type: EXPERIMENTAL
Intervention: 6-mg BID rivastigmine capsules
Number of subjects: 1195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1195
Study: 15789954

Group type: EXPERIMENTAL
Intervention: Any dental visit
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Corrective treatment
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Denture visit
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Extraction
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Dental cleaning (for stained teeth subgroup)
Number of subjects: 873
Study: 12448042

Group type: EXPERIMENTAL
Intervention: Evidence-Based Medicine (EBM)
Number of subjects: 0
Study: 10189977

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 9506733

Group type: COMPARATOR
Intervention: Methimazole alone (group 1)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Methimazole plus T4 to maintain TSH in upper normal range (group 2)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Methimazole plus T4 to suppress TSH below 0.6 mIU/L (group 3)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Group B (TSH < 1.0)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Group 1 (methimazole alone)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Group A (TSH > or = 1.0)
Number of subjects: 199
Study: 1770419

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate mouthrinse (CHX)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sterile water
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-irrigated controls
Number of subjects: 30
Study: 6579838

Group type: EXPERIMENTAL
Intervention: Intracervical application of 0.5 mg of prostaglandin E2 (PGE2) in 2 ml of gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravaginal application of 4 mg of prostaglandin E2 (PGE2) in 3 ml of gel
Number of subjects: 60
Study: 31898663

Group type: EXPERIMENTAL
Intervention: 6 fractions/week of RT (46 Gy/23 fractions/26 days) with injection Cisplatin 40 mg/m2
Number of subjects: 46

Group type: COMPARATOR
Intervention: 5 fractions/week of RT (46 Gy/23 fractions/31 days) with injection Cisplatin 40 mg/m2
Number of subjects: 46
Study: 30148941

Group type: EXPERIMENTAL
Intervention: Digital photographs used by expert evaluators to assess pressure lesions.
Number of subjects: 184

Group type: COMPARATOR
Intervention: Nursing registries of patients with pressure lesions.
Number of subjects: 184
Study: 26871847

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1.0 μg/kg loading dose over 10 minutes, followed by 0.5 μg/kg/h maintenance)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 40
Study: 24766306

Group type: EXPERIMENTAL
Intervention: Multiple interventions (lectures, plays, traffic department intervention, fire department intervention, emergency medical service intervention)
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Single intervention
Number of subjects: 535

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 535
Study: 22670617

Group type: EXPERIMENTAL
Intervention: Zinc pyrithione (ZPT) shampoo (n = 15)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Vehicle (n = 15)
Number of subjects: 31
Study: 21675032

Group type: EXPERIMENTAL
Intervention: Nigella sativa 2 gm/day
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Nigella sativa 1 gm/day
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Nigella sativa 3 gm/day
Number of subjects: 94
Study: 18609169

Group type: EXPERIMENTAL
Intervention: Oral daily treatment with 0.5 mg cyanocobalamin, 0.8 mg folic acid and 3 mg vitamin B(6) for 4 months
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo (double-blind)
Number of subjects: 209
Study: 16351809

Group type: EXPERIMENTAL
Intervention: Epi‐CH (carbon activated absorbing epirubicin)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (aqueous epirubicin)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epi‐CH
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 11840441

Group type: EXPERIMENTAL
Intervention: High-resolution MRI of the knee joint
Number of subjects: 0